| Excerpt | Relevance | Reference |
|---|
| "Twenty-six evaluable patients who had leiomyosarcoma of the uterus were treated with amonafide, 300 mg/m2, for 5 consecutive days every 3 weeks." | 9.08 | Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study. ( Asbury, R; Blessing, JA; Buller, R; Malfetano, JH; Sevin, BU; Walker, J, 1998) |
| "Twenty-six evaluable patients who had leiomyosarcoma of the uterus were treated with amonafide, 300 mg/m2, for 5 consecutive days every 3 weeks." | 5.08 | Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study. ( Asbury, R; Blessing, JA; Buller, R; Malfetano, JH; Sevin, BU; Walker, J, 1998) |